Fannie Mae, Freddie Mac shares tumble after conservatorship comments
BLOOMFIELD, Conn. - The Cigna Group (NYSE:CI) announced Tuesday that its Board of Directors has declared a cash dividend of $1.51 per share of common stock, representing a current yield of 2.05%. The dividend will be paid on September 18, 2025, to shareholders of record as of the close of business on September 4, 2025. According to InvestingPro data, the company has maintained dividend payments for 44 consecutive years and has raised its dividend for 4 consecutive years.
The health company, which operates under brands including Cigna Healthcare and Evernorth Health Services, maintains sales capabilities in more than 30 countries and jurisdictions worldwide. With a market capitalization of $80 billion and annual revenue of $255 billion, The Cigna Group serves approximately 183 million customer relationships globally.
The Cigna Group describes itself as a global health company focused on creating solutions for better health. The company’s shares are traded on the New York Stock Exchange under the ticker symbol CI. InvestingPro analysis indicates the stock is currently undervalued, trading at an attractive P/E ratio of 16.5x with a strong financial health rating. Discover more insights and 12 additional ProTips with an InvestingPro subscription.
In other recent news, Cigna Group has introduced new AI-powered digital tools to enhance customer experience in health insurance interactions. These features, available through the myCigna member portal, include a virtual assistant, personalized provider matching, and real-time cost tracking. Additionally, Michael J. Hennigan has joined Cigna’s Board of Directors, bringing extensive experience from his roles in the energy sector, including his position as Executive Chairman of Marathon Petroleum Corporation.
In another development, RBC Capital maintained its Outperform rating and a $371 price target for Cigna, citing favorable commercial utilization trends. The investment firm expressed satisfaction with utilization aligning with the company’s expectations following discussions with Cigna’s investor relations head. Furthermore, Cigna was among major health insurers that pledged to simplify prior authorization processes for medications and medical services in a meeting with U.S. health officials.
These recent developments highlight Cigna’s efforts to enhance its services and governance while maintaining confidence among analysts regarding its market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.